Sigrid Therapeutics
Quotes
Share:
Subscribe:

Sana Alajmovic CEO Sigrid Therapeutics

Mon, Jan 16, 2023 08:00 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Sigrid Therapeutics Announces Last Patient Last Visit in SHINE Clinical Trial Evaluating SiPore21® Gel for Sustained Blood Sugar Control Mon, Nov 04, 2024 08:30 CET

Sigrid enters strategic partnership with GetHealthy to meet growing US demand for Glucose Stabiliser as non-pharmaceutical solution to blood sugar management Mon, Sep 02, 2024 08:00 CET

Sigrid Therapeutics Completes Enrollment in SHINE to Evaluate SiPore21® Gel for Sustained Blood Sugar and Weight Management Tue, Jul 30, 2024 08:30 CET